Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 8,278,000 | 7,934,000 | 7,739,000 | 6,995,000 | 6,944,000 |
| Cost of Goods | 1,934,000 | 1,927,000 | 2,280,000 | 1,616,000 | 1,528,000 |
| Gross Profit | 6,344,000 | 6,007,000 | 5,459,000 | 5,379,000 | 5,416,000 |
| Operating Expenses | 3,582,000 | 3,104,000 | 3,665,000 | 2,674,000 | 2,742,000 |
| Operating Income | 2,762,000 | 2,903,000 | 1,794,000 | 2,705,000 | 2,674,000 |
| Interest Expense | 320,000 | 309,000 | 299,000 | 293,000 | 284,000 |
| Other Income | -430,000 | 203,000 | -302,000 | -317,000 | -37,000 |
| Pre-tax Income | 2,012,000 | 2,797,000 | 1,193,000 | 2,095,000 | 2,353,000 |
| Income Tax | 29,000 | 14,000 | 1,141,000 | 464,000 | 438,000 |
| Net Income Continuous | 1,983,000 | 2,783,000 | 52,000 | 1,631,000 | 1,915,000 |
| Net Income | $1,983,000 | $2,783,000 | $52,000 | $1,631,000 | $1,915,000 |
| EPS Basic Total Ops | 0.13 | 0.18 | 0.00 | 0.11 | 0.13 |
| EPS Basic Continuous Ops | 0.13 | 0.18 | 0.00 | 0.11 | 0.13 |
| EPS Diluted Total Ops | 0.13 | 0.18 | 0.00 | 0.11 | 0.13 |
| EPS Diluted Continuous Ops | 0.13 | 0.18 | 0.00 | 0.11 | 0.13 |
| EBITDA(a) | $2,775,000 | $3,551,000 | $1,861,000 | $2,767,000 | $3,016,000 |